1 Big risk facing Ozempic, Wegovy and other GLP-1 weight loss drugs | The motley fool

1 Big risk facing Ozempic, Wegovy and other GLP-1 weight loss drugs |  The motley fool

Weight loss medications have grown in popularity in recent years. People even use a drug like Ozempic, although it is only approved for diabetes, simply because it helps them lose weight. In the last three months of 2022 alone, more than 9 million prescriptions for weight loss drugs were dispensed… Continue Reading 1 Big risk facing Ozempic, Wegovy and other GLP-1 weight loss drugs | The motley fool